drugset / Trial / NCT00179582

Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

NCT00179582

Terminated 180 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS

Timeline

Start
2005-01
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject VSL#3 Other / unclassified